A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search

2022 Medicare Part D Formulary Search By Drug Letter

This is archive material for research purposes. Please see PDPFinder.com or MAFinder.com for current plans.
Select a Letter below:
Links to Summaries by State for LTC Drugs on LIS/SNP Plans:
AK  AL  AR  AZ  CA  CO  CT  DC  DE  FL  GA  HI  IA  ID  IL  IN  KS  KY  LA  MA  MD  ME  MI  MN  MO  MS  MT  NC  ND  NE  NH  NJ  NM  NV  NY  OH  OK  OR  PA  PR  RI  SC  SD  TN  TX  UT  VA  VT  WA  WI  WV  WY

Drug Names Containing the Letter J in Alphabetical Order.
Example: Lipitor® is found on letter page "L" as well as letter page "A" for Atorvastatin.

Drug Name
Packaging NDC On This Nbr of 2022 Formularies
PDPs MAPDs
ALOGLIPTIN-METFORMIN 12.5-1000 [Kazano]
(Alogliptin / Metformin)
    45802021172 1
PDPs
31
MAPDs
ALOGLIPTIN-METFORMIN 12.5-500 [Kazano]
(Alogliptin / Metformin)
    45802016972 1
PDPs
31
MAPDs
DEFERASIROX 180 MG GRANULE GRAN PACK [Jadenu]
()
1 UNIT   67877067684 40
PDPs
333
MAPDs
DEFERASIROX 180 MG TABLET [Jadenu]
()
TABLETS   70700027030 52
PDPs
360
MAPDs
DEFERASIROX 360 MG GRANULE GRAN PACK [Jadenu]
()
1 UNIT   67877067784 40
PDPs
333
MAPDs
DEFERASIROX 360 MG TABLET [Jadenu]
()
60 TABLETS   70710127703 52
PDPs
360
MAPDs
DEFERASIROX 90 MG GRANULE GRAN PACK [Jadenu]
()
1 UNIT   67877067584 40
PDPs
333
MAPDs
DEFERASIROX 90 MG TABLET [Jadenu]
()
62 TABLETS   70710127503 52
PDPs
360
MAPDs
DUTASTERIDE-TAMSULOSIN 0.5-0.4 CPMP 24HR [Jalyn]
(Dutasteride-Tamsulosin HCl)
90 units   10370028011 23
PDPs
306
MAPDs
FYAVOLV 0.5 MG-2.5 MCG TABLET [Jevantique]
(Ethinyl Estradiol, Norethindrone)
28 TABLETS   68180082773 29
PDPs
305
MAPDs
FYAVOLV 1 MG-5 MCG TABLET [Jinteli 1/5]
(Ethinyl Estradiol, Norethindrone)
28 TABLETS   68180082873 30
PDPs
312
MAPDs
IXIARO 6 UNIT(6 MCG)/0.5ML SYRINGE
(Japanese Encephalitis Vaccine Inactivated Adsorbed)
ml   42515000201 63
PDPs
404
MAPDs
JADENU 180 MG TABLET
(Deferasirox)
30 EA   00078065515 4
PDPs
4
MAPDs
JADENU 360 MG TABLET
(Deferasirox)
30 EA   00078065615 4
PDPs
3
MAPDs
JADENU 90 MG TABLET
(Deferasirox)
30 EA   00078065415 4
PDPs
3
MAPDs
JADENU SPRINKLE 180 MG
(Deferasirox)
    00078071315 2
PDPs
5
MAPDs
JADENU SPRINKLE 360 MG
(Deferasirox)
    00078072015 2
PDPs
5
MAPDs
JADENU SPRINKLE 90 MG
(Deferasirox)
    00078072715 2
PDPs
5
MAPDs
JAKAFI 10 MG TABLET
(ruxolitinib)
    50881001060 63
PDPs
404
MAPDs
JAKAFI 15 MG TABLET
(ruxolitinib)
    50881001560 63
PDPs
404
MAPDs
JAKAFI 20 MG TABLET
(ruxolitinib)
    50881002060 63
PDPs
404
MAPDs
JAKAFI 25 MG TABLET
(ruxolitinib)
    50881002560 63
PDPs
404
MAPDs
JAKAFI 5 MG TABLET
(ruxolitinib)
    50881000560 63
PDPs
404
MAPDs
JALYN 0.5-0.4 MG CAPSULE
(Dutasteride-Tamsulosin HCl)
30.000 EA   00173080913 0
PDPs
1
MAPDs
JANTOVEN 1 MG TABLET
(Warfarin Sodium)
100.000 EA   00832121100 63
PDPs
400
MAPDs
JANTOVEN 10 MG TABLET
(Warfarin Sodium)
100.000 EA   00832121900 63
PDPs
400
MAPDs
JANTOVEN 2 MG TABLET
(Warfarin Sodium)
100.000 EA   00832121200 63
PDPs
400
MAPDs
JANTOVEN 2.5MG TABLET
(Warfarin Sodium)
100 BOT 00832121300 63
PDPs
400
MAPDs
JANTOVEN 3 MG TABLET
(Warfarin Sodium)
100.000 EA   00832121400 63
PDPs
400
MAPDs
JANTOVEN 4 MG TABLET
(Warfarin Sodium)
100.000 EA   00832121500 63
PDPs
400
MAPDs
JANTOVEN 5 MG TABLET [Jantoven]
(Warfarin Sodium)
30 tablets   00832121610 63
PDPs
400
MAPDs
JANTOVEN 6MG TABLET
(Warfarin Sodium)
100 BOT 00832121700 63
PDPs
400
MAPDs
JANTOVEN 7.5MG TABLET
(Warfarin Sodium)
100 BOT 00832121800 63
PDPs
400
MAPDs
JANUMET 50-1,000 MG TABLET
(Sitagliptin-Metformin HCl)
60.000 EA   00006057761 59
PDPs
338
MAPDs
JANUMET 50-500 MG TABLET
(Sitagliptin-Metformin HCl)
60.000 EA   00006057561 59
PDPs
338
MAPDs
JANUMET XR 100-1,000 MG TABLET
(Sitagliptin-Metformin HCl)
30.000 EA   00006008131 59
PDPs
338
MAPDs
JANUMET XR 50-1,000 MG TABLET
(Sitagliptin-Metformin HCl)
60.000 EA   00006008061 59
PDPs
338
MAPDs
JANUMET XR 50-500 MG TABLET
(Sitagliptin-Metformin HCl)
60.000 EA   00006007861 59
PDPs
338
MAPDs
JANUVIA 25MG TABLET
(Sitagliptin Phosphate)
30 BOT 00006022131 59
PDPs
339
MAPDs
JANUVIA 50 MG TABLET
(Sitagliptin Phosphate)
30.000 EA   00006011231 59
PDPs
339
MAPDs
JANUVIA TABLET 100MG (30 CT)
(Sitagliptin Phosphate)
30 BOT 00006027731 59
PDPs
339
MAPDs
JARDIANCE 10 MG TABLET
(Empagliflozin)
30.000 EA   00597015230 61
PDPs
398
MAPDs
JARDIANCE 25 MG TABLET
(Empagliflozin)
30.000 EA   00597015330 61
PDPs
398
MAPDs
JASMIEL 3 MG-0.02 MG TABLET [Yaz]
(Drospirenone, Ethinyl Estradiol;Inert)
28 TABLETs   50102024023 57
PDPs
356
MAPDs
JATENZO 158 MG CAPSULE
(Testosterone Undecanoate)
60 CAPSULES   69087015812 0
PDPs
11
MAPDs
JATENZO 198 MG CAPSULE
(Testosterone Undecanoate)
CAPSULES   69087019812 0
PDPs
11
MAPDs
JATENZO 237 MG CAPSULE
(Testosterone Undecanoate)
60 CAPSULES   69087023712 0
PDPs
11
MAPDs
JENTADUETO 2.5 MG-1000 MG TABLET
(linagliptin/metformin)
60.000 EA   00597014860 43
PDPs
316
MAPDs
JENTADUETO 2.5 MG-500 MG TABLET
(linagliptin/metformin)
60.000 EA   00597014660 43
PDPs
316
MAPDs
JENTADUETO 2.5 MG-850 MG TABLET
(linagliptin/metformin)
60.000 EA   00597014760 43
PDPs
316
MAPDs
JENTADUETO XR 2.5 MG-1,000 MG
(linagliptin/metformin)
60.000 EA   00597027073 43
PDPs
313
MAPDs
JENTADUETO XR 5 MG-1,000 MG TABLET
(linagliptin/metformin)
30.000 EA   00597027533 43
PDPs
313
MAPDs
JINTELI 1 MG-5 MCG TABLET
(NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)
28.000 EA   00093312242 30
PDPs
311
MAPDs
JORNAY PM 100 MG CAPSULE ER SP
(Methylphenidate Hydrochloride)
30 UNITS   71376020503 0
PDPs
4
MAPDs
JORNAY PM 20 MG CAPSULE ER SP
(Methylphenidate Hydrochloride)
UNITS   71376020103 0
PDPs
4
MAPDs
JORNAY PM 40 MG CAPSULE ER SP
(Methylphenidate Hydrochloride)
UNITS   71376020203 0
PDPs
4
MAPDs
JORNAY PM 60 MG CAPSULE ER SP
(Methylphenidate Hydrochloride)
30 UNITS   71376020303 0
PDPs
4
MAPDs
JORNAY PM 80 MG CAPSULE ER SP
(Methylphenidate Hydrochloride)
UNITS   71376020403 0
PDPs
4
MAPDs
JUBLIA 10% TOPICAL SOLUTION
(Efinaconazole)
    00187540004 11
PDPs
54
MAPDs
JULEBER 28 DAY TABLET
(DESOGESTREL-ETHINYL ESTRADIOL)
28.000 EA   16714046404 57
PDPs
363
MAPDs
JULUCA 50-25 MG TABLET
(Dolutegravir Sodium and Rilpivirine Hydrochloride)
30 EA   49702024213 63
PDPs
404
MAPDs
JUNEL 1-0.02MG TABLET
(Norethindrone Ace & Ethinyl Estradiol)
3 X 21 BLPK 00555902542 57
PDPs
365
MAPDs
JUNEL 1.5-0.03MG TABLET
(Norethindrone Ace & Ethinyl Estradiol)
3 X 21 BLPK 00555902742 57
PDPs
366
MAPDs
JUNEL FE 1-0.02MG TABLET
(Norethindrone Ace & Ethinyl Estradiol-FE)
28 TABLETS BLPK 00555902658 57
PDPs
371
MAPDs
JUNEL FE 1.5-0.03MG TABLET
(Norethindrone Ace & Ethinyl Estradiol-FE)
28 BLPK 00555902858 57
PDPs
365
MAPDs
JUNEL FE 24 TABLET
(Norethindrone Ace & Ethinyl Estradiol-FE)
28.000 EA   00093532862 38
PDPs
269
MAPDs
JUXTAPID 10 MG CAPSULE
(lomitapide)
    76431011001 16
PDPs
247
MAPDs
JUXTAPID 20 MG CAPSULE
(lomitapide)
    76431012001 16
PDPs
247
MAPDs
JUXTAPID 30 MG CAPSULE
(lomitapide)
    76431013001 16
PDPs
245
MAPDs
JUXTAPID 5 MG CAPSULE
(lomitapide)
    76431010501 16
PDPs
247
MAPDs
JYNARQUE 15 MG TABLET
(Tolvaptan)
30 TABLETs   59148008213 4
PDPs
140
MAPDs
JYNARQUE 15 MG-15 MG TABLET SEQ
(Tolvaptan)
UNITS   59148007928 2
PDPs
137
MAPDs
JYNARQUE 30 MG TABLET
(Tolvaptan)
TABLETs   59148008313 4
PDPs
140
MAPDs
JYNARQUE 30 MG-15 MG TABLET SEQ
(Tolvaptan)
UNITS   59148008028 2
PDPs
137
MAPDs
JYNARQUE 45 MG-15 MG TABLET SEQ
(Tolvaptan)
units   59148008728 2
PDPs
139
MAPDs
JYNARQUE 60 MG-30 MG TABLET SEQ
(Tolvaptan)
units   59148008828 2
PDPs
139
MAPDs
JYNARQUE 90 MG-30 MG TABLET SEQ
(Tolvaptan)
units   59148008928 2
PDPs
139
MAPDs
KAZANO 12.5-1,000 MG TABLET
(alogliptin / metformin)
    64764033760 0
PDPs
4
MAPDs
KAZANO 12.5-500 MG TABLET
(alogliptin / metformin)
    64764033560 0
PDPs
4
MAPDs
NORETHIND-ETH ESTRAD 0.5-2.5 TABLET [Jevantique]
(Ethinyl Estradiol, Norethindrone)
28 TABLETS   75834012929 33
PDPs
308
MAPDs
VESTURA 3 MG-0.02 MG TABLET [Yaz]
(Drospirenone, Ethinyl Estradiol;Inert)
28 TABLETS   00093400028 51
PDPs
341
MAPDs
WARFARIN SODIUM 7.5 MG TABLET [Jantoven]
()
30 TABLETS   00093172301 63
PDPs
404
MAPDs



(Chart Source: Centers for Medicare and Medicaid files: CMS Data September 2022)





Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.